Clinical and pharmacological group: & nbsp

Dermatotropona funds

Included in the formulation
  • Isotrexin
    gel externally 
  • АТХ:

    D.10.A.D.54   Isotretinoin in combination with other drugs

    Pharmacodynamics:

    Combined drug with antiproliferative and antibacterial action.

    Isotretinoin

    Biologically active form of vitamin A has anti-inflammatory, antiseboric, keratolytic action. Stimulates the growth and differentiation of epithelial cells. It inhibits terminal differentiation of sebocytes and hyperproliferation of the sebaceous gland ducts, normalizes the composition of their secretions, facilitating its excretion. Reduces the inflammatory reaction around the sebaceous glands, reduces the production of sebum. It inhibits follicular keratinization, prevents the formation of acne caused by Propionibacterium acnes.

    Erythromycin

    Antibiotic from the group of macrolides. It disrupts the synthesis of microbial proteins at the level of the ribosomes, by binding to 50Sthe subunit of bacterial ribosomes, inhibits the process of translocation. It penetrates into cells and creates a high intracellular concentration.

    Has a bacteriostatic effect, in high concentrations has a bactericidal effect against the causative agents of diphtheria and pertussis, as well as pneumococci.

    Has a high activity against gram-positive cocci (staphylococci, streptococci).

    Erythromycin also exhibits high activity against chlamydia, leptospira, treponem, mycoplasma and toxoplasma.

    Pharmacokinetics:

    The drug for topical application, systemic action on the body does not.

    Indications:

    It is used to treat acne, with hyperpigmentation, rosacea.

    XII.L60-L75.L70   Acne

    XII.L60-L75.L71.9   Rosacea, unspecified

    XII.L60-L75.L71   Rosacea

    XII.L80-L99.L81.9   Disturbance of pigmentation, unspecified

    Contraindications:

    Individual intolerance, children under 12 years.

    Carefully:

    Applying cream to sensitive areas of the skin: the area around the eyes and neck. Hypersensitivity to the components of the drug.

    Pregnancy and lactation:

    Recommendations for FDA - Category B. Does not have a systemic effect - is used in pregnancy and lactation.

    Dosing and Administration:

    Outer on the affected skin 2 times a day. The course of treatment is 6-8 weeks.

    Side effects:

    Local reactions: irritation and burning of the skin, paresthesia, flushing and flaking of the skin, photosensitization.

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    It is possible to reduce the effect with simultaneous use of drugs containing antibiotics of the tetracycline group, as well as local glucocorticoids.

    Special instructions:

    When treatment is recommended to avoid ultraviolet radiation, as well as getting the drug in the eyes and on the wound surfaces.

    Instructions
    Up